MiMedx Overview
Company Headquarters: Georgia, US
Founded: 2008
Workforce: 1000+
Company Working: MiMedx is a biopharmaceutical company which develops, manufactures, and markets regenerative biologics using human placental allografts for multiple sectors of healthcare. The company processes human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce safe and effective allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx’s portfolio includes products based on amniotic membrane, umbilical cord, placental ECM, and amniotic fluid.
Strategy
MiMedx focuses on continuous innovations in regenerative medicine. The company also continuously evaluates strategic opportunities to acquire companies, divisions, technologies, products, and rights through licenses, distribution agreements, investments, and acquisitions to grow the business.
